Ajanta Pharma has been a great wealth-creator stock. It reported robust Q2FY15 results. However, have the valuations run up ahead of fundamentals and should we sell the stock?
Prof. Shivanand Mankekar Makes Bumper Profit & Bets Big Money On Two Top Quality Stocks
Prof. Shivanand Mankekar has raked in huge profits and put a huge chunk of money to work by buying truckloads of two top-quality stocks. We need to pay attention to his strategy
Meet Nandita Agarwal Parker Of Karma Capital & Check Out Her Winning Stock Picks
Nandita Agarwal Parker of Karma Capital is an ace stock picker with Rs. 420 Cr ($70M) in her kitty. We need to keep an eye on her stock picks
Ajay Relan’s Promise Comes True. MPS Surges 20% & Gives 286% Gain In 10M
Ajay Relan of CX Advisors deserves to be complimented for his brilliant stock picking. His stock pick, MPS, surged 20% today, giving a total return of 286% in just 10 months
Check Out The Multi-Bagger Stock Picks Of Porinju Veliyath
Porinju Veliyath has identified a few stocks which he claims offer a high margin of safety coupled with the potential for hefty gains
Daljeet Kohli Changes Mind On Kajaria Ceramics & Revokes Sell Call
Daljeet Kohli had earlier expressed concern over Kajaria Ceramics’ “aggressive” expansion plans & valuations and had recommended a ‘Sell’. However, its’ robust Q2FY15 results have caused a change of mind & recommendation
Still Not Too Late To Buy Stocks: Prashant Jain
If you are ruing having missed out on the hefty gains that flowed effortlessly from stocks and are feeling wary of investing now, you have to listen to Prashant Jain’s words of wisdom. He has put the situation in its proper perspective
The Business Model & “Moat” Of Repco Home Finance
R Varadarajan, MD, Repco Home Finance, has explained the business model and “moat” that the company has, which will keep competitors at bay and ensure steady growth
Mastek Has Potential For 100%+ Gains: Daljeet Kohli
Daljeet Kohli of IndiaNivesh has issued an update report on Mastek in the wake of its Q2FY15 results. He says that the results are “above expectation” and that the stock has a target price of Rs. 550, which means a 100%+ upside from the CMP of Rs. 258
Is Mohnish Pabrai Too Early In His Contrarian Pick J&K Bank?
We get a rare opportunity to watch how a contrarian investment pans out. Mohnish Pabrai has bought a truckload of J&K Bank at the time it is facing its worst crises. Is he too early? Is a contrarian investment really worth the pain it puts you through? How much money can you make out of it and after how much time? These are questions to which we can hope to get an answer from Mohnish Pabrai himself
Recent Comments